Startseite Mass Spectrometry-Based Proteomics: Current Status and Potential Use in Clinical Chemistry
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Mass Spectrometry-Based Proteomics: Current Status and Potential Use in Clinical Chemistry

  • Pierre-Alain Binz , Denis F. Hochstrasser und Ron D. Appel
Veröffentlicht/Copyright: 1. Juni 2005
Veröffentlichen auch Sie bei De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
Aus der Zeitschrift Band 41 Heft 12

Abstract

For some years now, scientists have been spending a lot of effort in developing methods to analyse and compare complex protein samples. One of the goals of such global analyses of what is known as proteomes is to discover specific protein markers–or fingerprints of protein markers−from various types of affected biological samples. Considering the battery of technologies currently available, mass spectrometry (MS) constitutes an essential tool in proteomics. We describe here the type of MS instrumentation that is currently dedicated to proteomics research. We also describe the major experimental workflows that are typically used in proteomics today, with a focus on those incorporating MS as a major analysis tool.

:
Published Online: 2005-06-01
Published in Print: 2003-12-04

Copyright © 2003 by Walter de Gruyter GmbH & Co. KG

Heruntergeladen am 16.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2003.237/html
Button zum nach oben scrollen